Get early access! Join the Twelve Data AI Assistant waitlist now.

VICO

OMX
Market closed
Access this stock data via API
Subscribe
Vicore Pharma Holding AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 109.3M 0 0 0
Cost of revenue
Gross profit 109.3M 0 0 0
Operating expense
Research & development 249.3M 276.3M 250.0M 271.8M
Selling general and admin 50.4M 44.6M 37.5M 21.6M
Other operating expenses 3.8M
Operating income -190.4M -320.9M -287.5M -293.4M
Non operating interest income
Income 21.1M 10.5M 913K 646K
Expense 8K 2K 8K 11K
Other income expense
Pretax income -168.9M -311.3M -288.8M -296.7M
Tax provision -256K -384K -384K -254K
Net income -168.6M -310.9M -288.4M -296.5M
Basic EPS -1.2 -3.1 -3.9 -4.1
Diluted EPS -1.2 -3.1 -3.9 -4.1
Basic average shares 136.8M 99.2M 74.2M 71.6M
Diluted average shares 136.8M 99.2M 74.2M 71.6M
EBITDA -166.6M -307.7M -284.7M -291.0M
Net income from continuing op. -194.2M -321.5M -290.7M -294.8M
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed (non-working day)
Main market opens in 1 day 10 hours 6 minutes

22:53
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).